XNYS · Healthcare · Medical Instruments & Supplies
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-23 | Q1 2026 | 1.68 | 2.13 | +26.79% | $844.9M | ✅ Beat | +3.49% | -3.91% | +2.17% |
| 2026-02-12 | Q4 2025 | 1.83 | 2.04 | +11.48% | $805.0M | ✅ Beat | +5.90% | +0.09% | -3.35% |
| 2025-10-23 |
| Q3 2025 |
| 1.68 |
| 1.96 |
| +16.67% |
| $804.6M |
| ✅ Beat |
| — |
| — |
| — |
| 2025-04-24 | Q1 2025 | 1.23 | 1.45 | +17.89% | $698.0M | ✅ Beat | +1.88% | -0.16% | +0.20% |
| 2025-02-13 | Q4 2024 | 1.73 | 1.82 | +5.20% | $748.8M | ✅ Beat | +7.84% | +2.28% | +16.25% |
| 2024-10-24 | Q3 2024 | 1.50 | 1.85 | +23.33% | $746.9M | ✅ Beat | -6.87% | -6.87% | -3.28% |
| 2024-07-25 | Q2 2024 | 1.74 | 1.52 | -12.64% | $702.1M | ❌ Miss | +2.74% | +9.07% | +9.50% |
| 2024-04-25 | Q1 2024 | 1.26 | 1.56 | +23.81% | $695.4M | ✅ Beat | -2.10% | +0.08% | -11.06% |
Showing last 8 quarters.